Text For Citation: 01 Item/Group: 009B Hazard:

29 CFR 1926.62(j)(2)(i)(A): The employer did not make available biological monitoring in the form of blood sampling and analysis for lead and zinc protoporphyrin levels to each employee covered under 29 CFR 1926.62(j)(1)(ii), at least every 2 months for the first 6 months and every 6 months thereafter: a) On July 6, 2017, the employer did not ensure that employees exposed to lead at or above the action level when performing lead abatement tasks, using manual scraping or sandblasting methods, received biological monitoring in the form of blood sampling and analysis for lead and zinc protoporphyrin at least every 2 months for the first 6 months and every 6 months thereafter. (1) An employee assigned to the worksite on August 24, 2016, did not receive follow-up biological monitoring in the form of blood sampling and analysis for lead and zinc protoporphyrin levels every 2 months for the first 6 months and every 6 months thereafter. The employee was provided follow-up biological monitoring on July 20, 2017, approximately 13 months after initial testing. (2) An employee assigned to the worksite on September 8, 2016, did not receive follow-up biological monitoring in the form of blood sampling and analysis for lead and zinc protoporphyrin levels every 2 months for the first 6 months and every 6 months thereafter. The employee was provided follow-up biological monitoring on July 13, 2017, approximately 10 months after initial testing. (3) An employee assigned to the worksite on September 30, 2016, did not receive follow-up biological monitoring in the form of blood sampling and analysis for lead and zinc protoporphyrin levels every 2 months for the first 6 months and every 6 months thereafter. The employee was provided follow-up biological monitoring on June 27, 2017, approximately 9 months after initial testing. (4) An employee assigned to the worksite on October 24, 2016, did not receive follow-up biological monitoring in the form of blood sampling and analysis for lead and zinc protoporphyrin levels every 2 months for the first 6 months and every 6 months thereafter. The employee was provided follow-up biological monitoring on June 27, 2017, approximately 8 months after initial testing. (5) An employee assigned to the worksite on December 1, 2016, did not receive follow-up biological monitoring in the form of blood sampling and analysis for lead and zinc protoporphyrin levels every 2 months for the first 6 months and every 6 months thereafter. The employee was provided follow-up biological monitoring on July 7, 2017, approximately 7 months after initial testing.